We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.92%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$223B
AUM Growth
+$132B
Cap. Flow
+$128B
Cap. Flow %
57.4%
Top 10 Hldgs %
41.38%
Holding
5,646
New
798
Increased
2,634
Reduced
1,094
Closed
385

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.5B
2
AAPL icon
Apple
AAPL
+$1.68B
3
TSLA icon
Tesla
TSLA
+$951M
4
JNJ icon
Johnson & Johnson
JNJ
+$750M
5
UNH icon
UnitedHealth
UNH
+$703M

Sector Composition

Rank Sector Weight
1 Technology 12.48%
2 Healthcare 7.36%
3 Financials 6.5%
4 Consumer Discretionary 5.35%
5 Industrials 3.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMQ
5001
Trilogy Metals
TMQ
$549M
$110 ﹤0.01%
200
CYRN
5002
DELISTED
CYREN Ltd.
CYRN
$110 ﹤0.01%
177
ZSQR
5003
Z Squared Inc
ZSQR
$275M
$103 ﹤0.01%
+3
New +$266
CGNT icon
5004
Cognyte Software
CGNT
$647M
$93 ﹤0.01%
30
HEPA
5005
DELISTED
Hepion Pharmaceuticals
HEPA
0
DYAI icon
5006
Dyadic International
DYAI
$39M
$89 ﹤0.01%
72
NVVE
5007
DELISTED
Nuvve Holding Corp
NVVE
0
BNT
5008
Brookfield Wealth Solutions
BNT
$11.7B
$64 ﹤0.01%
3
-450
-99% -$12K
SKM icon
5009
SK Telecom
SKM
$12.2B
$62 ﹤0.01%
3
CLLS
5010
Cellectis
CLLS
$287M
$59 ﹤0.01%
28
-622
-96% -$1.41K
YANG icon
5011
Direxion Daily FTSE China Bear 3X ETF
YANG
$82.7M
0
SCKT icon
5012
Socket Mobile
SCKT
$3.67M
$58 ﹤0.01%
30
FINMW
5013
DELISTED
Marlin Technology Corporation Warrant
FINMW
$54 ﹤0.01%
33,728
FNCH
5014
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$51 ﹤0.01%
4
MAXN
5015
DELISTED
Maxeon Solar Technologies
MAXN
-194
Closed -$384K
SYM icon
5016
Symbotic
SYM
$5.46B
$48 ﹤0.01%
4
-38,730
-100% -$451K
VGZ icon
5017
Vista Gold
VGZ
$260M
$47 ﹤0.01%
94
SYRE icon
5018
Spyre Therapeutics
SYRE
$8.81B
$45 ﹤0.01%
4
MOR
5019
DELISTED
MorphoSys AG American Depositary Shares
MOR
$43 ﹤0.01%
+12
New +$54
PTOCW
5020
DELISTED
Pine Technology Acquisition Corp. Warrant
PTOCW
$42 ﹤0.01%
24,481
-13,900
-36% -$453
CIXX
5021
DELISTED
CI Financial Corp.
CIXX
$40 ﹤0.01%
4
KNDI
5022
Kandi Technologies Group
KNDI
$65.7M
$32 ﹤0.01%
14
STRY
5023
DELISTED
Starry Group Holdings, Inc.
STRY
$32 ﹤0.01%
656
-352
-35% -$176
SLACW
5024
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$31 ﹤0.01%
520
TDW.WS.A
5025
DELISTED
Tidewater Inc. Series A Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.A
$31 ﹤0.01%
28

Similar funds

Barclays's Q4 2022 Portfolio in Review

As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.

  • Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
  • Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
  • Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
  • Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
  • Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
  • Barclays opened 798 new positions and closed 385 in Q4 2022.
  • Barclays's portfolio value rose 144% quarter-over-quarter to $223B.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.